Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EsCAPE2: Smoking Cessation in Periodontal Therapy
NCT02744417Completed
- Start
- Aug 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Single-blind, single-arm trial of varenicline, bupropion and nicotine in Tobacco Use Disorder (TUD). Primary endpoint: Clinical Attachment Level at 12 months. Started Aug 2010; status: completed.
02
Drugs
vareniclinebupropionnicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02744417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744417.